Therapeutic Use of rTMS in Pediatric ASD and ADHD Cohorts
RecruitingNCT06069323Phase: NAStarted 2023-06-01
Summary
In this interventional, pilot clinical trial investigators will stimulate the dorsolateral prefrontal cortex (DLPFC) in patients with Autism and ADHD. The goal of the study is to improve Cognition and
Eligibility
Sex
ALL
Min Age
6 Years
Max Age
18 Years
Locations
Neuropsychiatric Unit for Child and Adolescent, at General HFoggia, Italy
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06069323